Clinical trials
Neoplasms clinical trials
Below are recruiting neoplasms clinical trials, each written for real people, not researchers. We’re tracking 1,640 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07698366Recruiting
Ultrasound screening for breast cancer in older women
This study tests if ultrasound screening can help find breast cancer early in women aged 65–80 who live in the community. Participants will have an ultrasound exam to check for signs of breast cancer.
Kunshan, JiangsuAges 65–80 - NCT07566156RecruitingPhase 3
New drug combination vs. radiation for bladder cancer preservation
This trial tests whether two drugs (enfortumab vedotin and pembrolizumab) work better than radiation with chemotherapy for muscle-invasive bladder cancer. The goal is to treat your cancer while keeping your bladder instead of removing it.
Santa Barbara, CaliforniaAges 18 years+ - NCT07859488Recruiting
Delirium risk after cancer surgery
After surgery for cancer in the belly area, some older adults become confused or have memory problems. This study looks for early signs in the blood that might predict this, so doctors can help prevent it.
Istanbul, IstanbulAges 65 years+ - NCT07874308Recruiting
Preventing nausea and vomiting from chemotherapy
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
Guangzhou, GuangdongAges 18 years+ - NCT07558304Recruiting
Comparing two stent placements for bile duct blockage from cancer
This trial compares two ways of placing a metal stent to open a blocked bile duct caused by cancer. The goal is to see which method works better and has fewer complications.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07684612RecruitingPhase 3
New drug combo for recurrent ovarian cancer
This trial tests a new drug called mocertatug rezetecan combined with bevacizumab against standard platinum chemo plus bevacizumab. It's for women with ovarian cancer that came back after treatment and is still sensitive to platinum drugs.
Newcastle, New South WalesAges 18 years+ - NCT07689201RecruitingPhase 2
Studying a new targeted drug for advanced GIST after other treatments fail
This study tests a new pill called velzatinib for people with GIST that has spread or can't be removed by surgery, after other treatments have stopped working. It may help shrink the tumor or slow its growth.
FukuokaAges 18 years+ - NCT07714044Recruiting
Genetics of blood cancers study
This study looks at the genes that may be linked to blood cancers. You provide a saliva sample and answer a health survey at home, and your DNA may help researchers understand why some people get blood cancers.
Piscataway, New JerseyAges 18–110 - NCT07714980Recruiting
Acupoint stimulation timing for stomach cancer surgery recovery
This trial tests whether giving a gentle, needle-free acupoint stimulation before or after stomach cancer surgery helps speed up recovery. The stimulation uses a small device on the skin, similar to a tens unit, to support recovery after laparoscopic gastrectomy.
Dongying, ShandongAges 18–80 - NCT07449208Recruiting
Esophagectomy leak risk registry study
This study follows people having surgery to remove part of the esophagus (esophagectomy) who are at higher risk for a leak where the esophagus is reconnected. The goal is to learn more about who develops leaks and how to prevent them.
Basking Ridge, New JerseyAges 18 years+ - NCT07435701RecruitingPhase 1/Phase 2
Cell injection into belly for advanced ovarian cancer with fluid buildup
This trial tests a new type of therapy where special cells (called SK-NK cells) are injected directly into the belly to treat fluid buildup (ascites) caused by advanced ovarian cancer. It is for patients whose cancer has not responded to at least two prior treatments and who have no other standard options left.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07838519Enrolling by invitation
Personalized lung cancer screening for veterans
This study tests a personalized approach to help veterans decide if lung cancer screening is right for them. It aims to improve early detection by considering each person's unique risk factors, such as smoking history, military exposures, and lung health.
Aurora, ColoradoAges 50–80 - NCT07751757Enrolling by invitation
AI tool to detect emotional state in cancer patients
This trial uses artificial intelligence to understand how cancer patients are feeling emotionally, which could help doctors provide better support. Participants will answer some questionnaires and have their responses analyzed by AI.
BeijingAges 18 years+ - NCT07750275Enrolling by invitation
Safer, cheaper liver surgery with small incisions
This study looks at different ways doctors cut and seal the liver during keyhole surgery. It aims to find the safest and most cost-effective method for removing liver tumors or other growths.
Campobasso, CBAges 18 years+ - NCT07706673Enrolling by invitationPhase 4
Long-term follow-up for HPV vaccine study participants
This study checks on people who got one or two doses of the HPV vaccine (Gardasil 9) during the earlier ESCUDDO study. It helps researchers see how well the vaccine protects over many years, which might lead to simpler vaccination schedules.
Liberia, Guanacaste ProvinceAges 18 years+ - NCT07695116Enrolling by invitation
Cancer study in six Eastern Caribbean islands
This study looks at the experiences of cancer survivors and their caregivers in Antigua, Dominica, Grenada, Saint Kitts, Saint Lucia, and Saint Vincent. Researchers will review medical records and talk to survivors to understand their journey.
St John'sAges 18 years+ - NCT07651345Enrolling by invitation
Helping Women Return for Overdue Breast Cancer Screening
This study tests different ways to encourage women in Singapore to return for mammograms (breast cancer screening) if they've fallen behind. You'd be randomly assigned to receive different types of reminders or support to help you schedule your screening.
SingaporeAges 50–69 - NCT07583160Enrolling by invitationPhase 1
YS247 Vaccine for Advanced Prostate Cancer
This trial tests a personalized cancer vaccine (YS247) designed to train your immune system to recognize and fight your prostate cancer. It may help slow or stop cancer growth in men whose cancer has spread and stopped responding to standard hormone treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07517393Recruiting
Creating a Digital Lung Model Using AI and CT Scans
This study collects information from your chest CT scans and medical history to build an artificial intelligence model of how your lungs work. This 'digital twin' may help doctors better understand and predict lung health in the future.
Peschiera del Garda, VeronaAges 18 years+ - NCT07504913Recruiting
Quality of life survey for stomach cancer patients after surgery
This study tests a new questionnaire to measure quality of life in people who had surgery to remove stomach cancer. If you had surgery for stomach cancer between 1 month and 5 years ago and are cancer-free now, your answers can help improve care.
Badalona, BarcelonaAges 18 years+ - NCT07504471RecruitingPhase 2
Bicarbonate plus chemo and immunotherapy for pancreatic cancer liver spread
This trial tests adding sodium bicarbonate to a chemotherapy plus immunotherapy regimen for pancreatic cancer that has spread to the liver. The goal is to see if this combination helps shrink tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07500428Recruiting
Breast ultrasound AI study using existing images
This study uses existing breast ultrasound images to test how well artificial intelligence (AI) can interpret them. It may help improve future breast cancer detection tools.
BeijingAges 18–75 - NCT07499128Enrolling by invitation
Continuous temperature monitoring for cytokine release syndrome
This study tests a wearable device that continuously monitors your body temperature to detect cytokine release syndrome, a possible side effect of certain immunotherapies. The goal is to catch it early so you can get treatment faster.
Bethesda, MarylandAges 18–120 - NCT07495072Recruiting
Timing of Blad-Care during BCG therapy for bladder cancer
This trial tests whether giving Blad-Care early or later during BCG treatment changes outcomes for people with non-muscle-invasive bladder cancer. BCG is a standard therapy that uses a germ to help your immune system fight cancer, and Blad-Care is a device used in the bladder.
Seoul, Dongdaemun-guAges 19 years+
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasms?
- Yes. Clin2 currently lists 1,640 recruiting neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.